Trials / Conditions / Focal Cortical Dysplasia

Focal Cortical Dysplasia

10 registered clinical trials studyying Focal Cortical Dysplasia — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), NCT07287202	Sovargen	Phase 1 / Phase 2
Completed	Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered D NCT06975605	GRIN Therapeutics, Inc.	Phase 1
Terminated	Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itrac NCT06965881	GRIN Therapeutics, Inc.	Phase 1
Active Not Recruiting	Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavi NCT06392009	GRIN Therapeutics, Inc.	Phase 1 / Phase 2
Unknown	First-in-human Experience Using Novel Ultraflexible Low-impedance Electrode Arrays: an IDEAL Stage 1 Study NCT06116279	Great Ormond Street Hospital for Children NHS Foundation Trust	N/A
Recruiting	Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue) NCT06053671	King's College Hospital NHS Trust	N/A
Withdrawn	Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery NCT04344626	University of California, Los Angeles	N/A
Unknown	Study of Predictive Biomarkers for Rational Management of Drug-resistant Epilepsy Associated With Focal Cortic NCT03321240	University Hospital, Strasbourg, France	—
Completed	A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in T NCT02451696	NYU Langone Health	Phase 2
Completed	Determining the Extent of Diffusion Tensor Abnormalities in Focal Cortical Dysplasia NCT00687024	The Hospital for Sick Children	—